| Nov 5 |
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
|
| Oct 29 |
Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
|
| Oct 24 |
Compugen Gears Up to Report Q3 Earnings: Here's What to Expect
|
| Oct 7 |
Compugen to Present New Clinical Data at SITC 2024
|
| Sep 11 |
Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
| Sep 9 |
Compugen to Present at Single Cell Genomics 2024 Conference
|
| Aug 29 |
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 26 |
Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?
|
| Aug 11 |
Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts
|
| Aug 10 |
Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript
|
